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ABBREVIATIONS
ICH Intracranial hypertension
OFC Occipitofrontal circumference
OSA Obstructive sleep apnea
AIM To evaluate the impact of risk factors for intracranial hypertension (ICH) on cerebral
cortex thickness in syndromic craniosynostosis.
METHOD ICH risk factors including papilloedema, hydrocephalus, obstructive sleep apnea
(OSA), cerebellar tonsillar position, occipitofrontal circumference (OFC) curve deflection, age,
and sex were collected from the records of patients with syndromic craniosynostosis (Apert,
Crouzon, Pfeiffer, Muenke, Saethre-Chotzen syndromes) and imaging. Magnetic resonance
images were analysed and exported for statistical analysis. A linear mixed model was
developed to determine correlations with cerebral cortex thickness changes.
RESULTS In total, 171 scans from 107 patients (83 males, 88 females, mean age 8y 10mo,
range 1y 1mo–34y, SD 5y 9mo) were evaluated. Mean cortical thickness in this cohort was
2.78mm (SD 0.17). Previous findings of papilloedema (p=0.036) and of hydrocephalus
(p=0.007) were independently associated with cortical thinning. Cortical thickness did not
vary significantly by sex (p=0.534), syndrome (p=0.896), OSA (p=0.464), OFC (p=0.375), or
tonsillar position (p=0.682).
INTERPRETATION Detection of papilloedema or hydrocephalus in syndromic craniosynostosis
is associated with significant changes in cortical thickness, supporting the need for
preventative rather than reactive treatment strategies.
Craniosynostosis is a congenital disease of premature fusion
of calvarial sutures, which occurs in 1 to 2000 or 2500
births.1 This results in craniocerebral disproportion and
skull deformity, based on the location and number of sutures
involved. Syndromic variants of the disease (most commonly
Apert, Crouzon, Pfeiffer, Muenke, and Saethre-Chotzen
syndromes), which are attributable to single gene mutations
or chromosomal abnormalities, comprise 20% of these cases
and are characterized by additional defects such as limb, ear,
or midface deformities.1,2 Of particular concern in patients
with the syndrome is the increased incidence of intracranial
hypertension (ICH), which may lead to cognitive or visual
impairment.3,4 Previous studies have demonstrated ICH
prevalence in 61% to 83% of patients with the syndrome
before surgery, with 35% to 47% developing recurrent ICH
after a vault expansion procedure.4–8
The detection of ICH is a frequent indication for
surgical intervention in patients with craniosynostosis.
The criterion standard method of measurement is
intraparenchymal pressure monitoring, which is too inva-
sive for use as a screening tool. Therefore, less invasive
methods are frequently utilized along with the clinical
examination and history. In our centre, these include fun-
doscopy, optical coherence tomography, and magnetic res-
onance imaging (MRI). Because of the complexity of the
pathogenesis of ICH in these patients, further evaluation
of contributing factors is often necessary and may include
polysomnography to assess obstructive sleep apnea (OSA),
occipitofrontal circumference (OFC) measurement to
determine the risk of craniocerebral disproportion, and
radiographic assessment for hydrocephalus or Chiari type I
malformation.9,10
It remains unclear what effects ICH may have on struc-
tural neurological development in syndromic craniosynos-
tosis. Cortical thickness is an important in vivo biomarker
for cognitive ability and may provide valuable insight
regarding potential changes due to ICH.11–15 As a subcom-
ponent of cortical volume, cortical thickness reflects
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neuronal density per column, dendritic arborization, and
glial support.16 Development of the cortex occurs rapidly
during childhood and adolescence, and cortical thinning
has been correlated with reductions in IQ, making it an
appropriate biomarker for evaluation in patients with syn-
dromic craniosynostosis.14,15,17 Understanding structural
sequelae from positive clinical and imaging evaluation for
ICH will better inform clinical decision making and timing
of surgical intervention. The aim of this study was to eval-
uate the effect of ICH risk factors and markers on cortical
thickness in patients with syndromic craniosynostosis.
METHOD
Participants
Medical and imaging records of all patients with syndromic
craniosynostosis (Apert, Crouzon, Pfeiffer, Muenke, Saethre-
Chotzen syndromes) at the Dutch Craniofacial Center (Eras-
mus University Medical Center) were reviewed from 2008 to
2018. All MRI studies, including a 3D T1-weighted fast
spoiled gradient-echo sequence from these patients were
included in the study, often resulting in multiple scans per
patient; however, some of these scans were eventually excluded
because of image processing failure. Children with isolated
single suture synostosis were excluded. Additional clinical and
demographic data were collected for further analysis. Clinical
management of patients with the syndrome included sched-
uled vault expansion in the first year of life. Subsequent devel-
opment of ICH was treated according to suspected cause (e.g.
secondary vault expansion for growth restriction, continuous
positive airway pressure/midface advancement for OSA). This
study was approved by the institutional review board of Eras-
mus Medical Centre (MEC-2014-461).
Papilloedema
Patients with craniosynostosis were evaluated by fun-
doscopy at follow-up for evidence of papilloedema, indicat-
ing ICH.18 All patients underwent fundoscopy one day
before initial vault expansion, 3 months postoperatively,
biannually until the age of 4 years, and then annually until
the age of 6 years. After age 6 years, fundoscopy was only
performed on clinical indication. When papilloedema was
detected it was followed up with confirmatory fundoscopy
and imaging 4 to 6 weeks later. Patients were considered
to have a finding of papilloedema as noted in the medical
chart from the funduscopic examination by an experienced
paediatric ophthalmologist after clinical exclusion of pseu-
dopapilloedema due to hypermetropia.
OSA
A diagnosis of OSA was made by clinical and ambulatory
sleep studies. Polysomnography data were analysed and
scored by a trained physician according to the American
Academy of Sleep Medicine guideline for scoring paedi-
atric respiratory events19 and subsequently the obstructive
apnea-hypopnea index was calculated. The obstructive
apnea-hypopnea index is the number of obstructive and
mixed apneas and obstructive hypopneas with desaturation/
arousal, divided by the total sleep time.10 Patients with an
obstructive apnea-hypopnea index of 5 or more were con-
sidered to have moderate to severe sleep apnea, which may
cause ICH.20 Dates of the sleep studies were recorded and
any history of moderate to severe OSA before the date of
MRI acquisition was considered positive in our analysis.
OFC
The OFC reliably predicts intracranial volume in syn-
dromic craniosynostosis. Therefore, OFC curve deflection
is seen as a risk factor for ICH.9,20 OFC was manually
measured preoperatively every 3 months until the age of 2
years, every 6 months until the age of 4 years, and from
then annually until age 18 years. Growth curve deflection
was defined as a standard deviation fall of 0.5 or more
from baseline over 2 years.
Hydrocephalus
Ventricular size was manually assessed on MRI. All scans
were reviewed on a 3D reformatting platform (Aquar-
iusNET; TeraRecon, Inc., Melbourne, Australia) to align
scans in all planes. The size of the lateral ventricles was eval-
uated on axial planes using the frontal occipital horn ratio,
ventricles were considered enlarged when the frontal occipi-
tal horn ratio was greater than 0.34.21 Hydrocephalus was
considered present when ventricles were progressively
enlarged on two or more consecutive MRI studies. Progres-
sive hydrocephalus after vault expansion was treated with
third ventriculostomy or ventriculoperitoneal shunting.
Cerebellum tonsillar position
The cerebellum tonsillar position was manually measured
in the mid-sagittal and adjacent magnetic resonance slices
at the level of the lowest observable point, as previously
described.22 The level of the foramen magnum was set as 0
and measurements above this level were considered nega-
tive and those below as positive. All measurements were
performed on 3D reformatting software (AquariusNET) to
align scans in all planes.
MRI acquisition
All MRI was performed on a 1.5 T scanner (GE Health-
care, MR Signa Excite HD, Little Chalfont, UK) and the
imaging protocol included a 3D T1-weighted fast spoiled
gradient-echo magnetic resonance sequence. Imaging
parameters for craniosynostosis patients were as follows:
2mm slice thickness, no slice gap; field of view 22.4cm;
matrix size 2249224; in plane resolution of 1mm; echo
time 3.1ms; and repetition time 9.9ms.22
Cortical thickness
MRI dicom files were exported and converted to NIfTI-1
file format on a computer cluster with Scientific Linux
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(Fermilab, Batavia, IL, USA) as the operating system and
containing preloaded FreeSurfer software modules, version
6.0 (https://surfer.nmr.mgh.harvard.edu). FreeSurfer is a
brain imaging software package, developed by the Athi-
noula A Martinos Center for Biomedical Imaging at Mas-
sachusetts General Hospital, for analysing MRI data. It is
an important tool in functional brain mapping and facili-
tates the visualization of the functional regions of the
highly folded cerebral cortex. FreeSurfer is a fully-auto-
mated image processing software package, which allows for
surface-based registration analysis and has demonstrated
some advantages over more traditional voxel-based mor-
phometric techniques, which are prone to partial voluming
effects.23 The processing methodologies used by FreeSur-
fer have previously been validated and described in
detail.24–27
All T1-weighted scans from our cohort were processed by
the FreeSurfer ‘auto-recon-all’ pipeline. The quality of the
scans and surfaces generated by FreeSurfer were then
inspected after pipeline for accuracy and error logs were
reviewed for scans which failed to complete the pipeline.
Visual inspection is common practice in studies using auto-
mated tools such as FreeSurfer, to ensure that surfaces are
not including the dura or excluding entire segments of cortex
due to incorrect thresholding.17 Error logs revealed uncor-
rectable topology errors due to excessive motion artifact or
poor grey-white differentiation in younger patients. Scans
which failed to complete the auto-recon-all pipeline because
of excessive motion artifacts and/or poor quality, or scans
which demonstrated white matter or pial surface errors, were
excluded from further analysis. Vertex-wise cortical thick-
ness estimates were then generated by the FreeSurfer pack-
age for successful scans and exported for statistical analysis.
Statistical analysis
All acquired biomarker data were imported into R statisti-
cal software, version 3.6.1, 2019 (R Core Team, Vienna,
Austria) and a multivariate linear mixed model was used to
account for multiple measurements, age, and sex (non-lin-
ear mixed effects package). Patient identity was the only
random effect term included. Syndrome, papilloedema,
OFC deflection, and hydrocephalus were all evaluated as
potential interaction terms, but were not found to improve
the model fit by Akaike information criterion, therefore no
interaction terms were used. Necessary assumptions for
linear mixed models were also evaluated. Linearity was
assessed graphically, using the lattice package). Homogene-
ity of variance was evaluated with Levene’s test (p=0.90)
and normal distribution of residuals was evaluated via Q–Q
plot, using car and stats packages. No transformation was
necessary. Global cortical thickness was calculated as the
average measurement between left and right hemisphere
outputs from FreeSurfer and was treated as the primary
outcome. All variables except for age, tonsillar position,
and cortical thickness were evaluated as categorical. p-val-
ues and 95% confidence intervals were calculated for each
model variable; a significance level of 0.05 was considered
in all tests. Graphs were created using the ggplot2 package
with a loess smoother.
RESULTS
In total, 171 MRI scans of 107 patients with syndromic cran-
iosynostosis were successfully processed and included for
analysis (Fig. S1, online supporting information). Of those
excluded, 83% were considered too young (<2y) to expect
consistent grey-white matter differentiation at a level suit-
able for FreeSurfer analysis. The final number of scans per
syndrome were as follows: Apert, 38; Crouzon, 68; Muenke,
25; Pfeiffer, 18; and Saethre-Chotzen, 22 (Table 1).
Mean global cortical thickness for the entire study popu-
lation was 2.78mm (SD 0.17, range 2.34–3.25mm). Corti-
cal thickness estimates generated by FreeSurfer were
overlaid onto the pial surface of a patient with Crouzon
syndrome (Fig. 1). The average age of the patients at the
time of MRI was 8 years 10 months (range 1y 1mo–34y).
Our model demonstrated a significant association between
a historical finding of papilloedema and cortical thickness
(p=0.036) (Fig. 2). Patients with a finding of hydrocephalus
were also shown to have significantly thinner cortices
(p=0.007). A history of OFC curve deflection (p=0.375),
moderate to severe OSA (p=0.464), or tonsillar position
(p=0.682) did not have a significant impact. Last, syndrome
diagnosis and sex were both found to have non-significant
influences on cortical thickness in our cohort.
DISCUSSION
In this study we evaluated the effect of various ICH risk fac-
tors on cortical thickness in syndromic craniosynostosis.
Historical findings of papilloedema as well as hydrocephalus
were found to result in a thinner cortex. Other factors asso-
ciated with development of ICH were not correlated with
Table 1: Linear mixed model of the average global cortical thickness of
107 patients with syndromic craniosynostosis with 171 magnetic reso-
nance imaging (MRI) scans, including repeated scans
Grouping
MRIs, n
(%)
Mean thickness
(range) p
(+) Hydrocephalus 25 (14.6) 2.71 (2.34–3.22) 0.007
(+) Papilloedema 83 (48.5) 2.73 (2.34–3.22) 0.036
(+) OSA 30 (17.5) 2.79 (2.51–3.01) 0.464
(+) OFC 66 (38.6) 2.83 (2.49–3.25) 0.375
Tonsillar position – – 0.682
Sex – – 0.534
Male 83 (48.5) 2.80 (2.34–3.25) –
Female 88 (51.5) 2.78 (2.41–3.14) –
Syndrome – – 0.832
Apert 38 (22.2) 2.81 (2.52–3.13) –
Crouzon 68 (39.8) 2.77 (2.52–3.06) –
Muenke 25 (14.6) 2.84 (2.49–3.09) -
Pfeiffer 18 (10.5) 2.76 (2.51–3.03) –
Saethre-
Chotzen
22 (12.9) 2.74 (2.37–3.09) –
Age – – <0.001
Total MRIs 171 2.78 (2.34–3.25) –
Thickness values are reported in millimetres. OSA, obstructive
sleep apnea; OFC, occipitofrontal circumference.
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cortical thickness changes. Syndrome diagnosis, independent
of other detected indicators (e.g. hydrocephalus, papil-
loedema), did not affect cortical thickness.
In typically developing children, natural development of
the cerebral cortex results in a non-linear thinning pattern
over time, with a significant increase in rate occurring dur-
ing adolescence.28 This process can be understood as a
natural decline in thickness driven by synaptic pruning and
guided by the stimulation level in critical periods of devel-
opment.29–32 Our study demonstrates a similar cortical
maturation pattern in patients with syndromic craniosynos-
tosis, with age correlating to a thinner cortex.
In the current study, we found the presence of papil-
loedema to be significantly correlated with global cortical
thinning in patients with syndromic craniosynostosis. Previ-
ous work by Tuite et al. demonstrated papilloedema to be a
reliable tool for the diagnosis of ICH in patients with cran-
iosynostosis, with an overall specificity of 98% but with an
age-dependent sensitivity of 100% only for patients over the
age of 8 years.18 Furthermore, it has been shown that papil-
loedema does not occur as a result of transient elevations in
intracranial pressure but rather arises from prolonged expo-
sure, leading to axoplasmic flow stasis, neuronal swelling,
and extracellular fluid accumulation.33 The necessity of pro-
longed ICH exposure for papilloedema detection could
explain why it occurs in the context of accelerated cortical
thinning and other metrics have not. By the time ICH is
detectable as papilloedema, cortical neurons may have
already sustained sufficient stress to result in aberrant
remodeling, thereby limiting neuronal density and dendritic
arborization. This process is critical to establishing norma-
tive cytoarchitecture of the cortex and disruption would
explain the thinning pattern observed in this study. Further-
more, this pattern seems to mirror that of hydrocephalus,
for which a causal relationship is generally accepted. It is
possible that a causal relationship does exist between papil-
loedema and cortical thinning; however, to prove this would
require successful processing of the preoperative scans in
neonates, which are unavailable at present.
Our data suggest that once papilloedema is clinically
observable, its association with cortical thinning will con-
tinue throughout future radiographic evaluation of these
patients, as evidenced by sustained reductions as patients age
(Fig. 2). Given that structural neurological change has
already occurred at the time of papilloedema detection, this
calls into question whether waiting for evidence of sustained
ICH exposure is the best course of action in treating these
patients. Although preventative surgery does not guarantee
patients will not develop ICH during the years of childhood,
we feel it offers a distinct advantage by alleviating skull
growth restriction during a critical period of brain develop-
ment within the first year of life. An aim of this study was to
demonstrate that this is an important intervention given that
at the time of detection of papilloedema, cortical thinning
has already occurred. Indeed, further investigation into alter-
native tests allowing for earlier detection and better risk
stratification is warranted.
A finding of hydrocephalus was also shown to result in
thinner cortices. This finding confirms previous studies
demonstrating varying levels of cortical thinning and grey
matter reduction according to the severity of hydro-
cephalus, in both children and animal models.34–36 The
pathogenesis of hydrocephalus in craniosynostosis is
thought to be multifactorial. Primary causes are often con-
sidered to be impaired cerebrospinal fluid (CSF) reabsorp-
tion, overproduction of CSF at the choroid plexus, Chiari
type I malformation, and/or increased venous outflow
resistance from progressive crowding of the posterior fossa,
or at the level of third ventricle.37 Microstructurally, this
results in widespread neuronal swelling, increased extracel-
lular space, and myelination delay.38 It is not surprising,
then, that the shared cellular pathology of hydrocephalus
and papilloedema is reflected in similar changes to the
cerebral cortex. Although patients with papilloedema may
also present with hydrocephalus, we report only 18 out of
83 cases of this in our cohort. Furthermore, it is important
to emphasize that hydrocephalus and papilloedema were
independently associated with cortical thinning in our
model after accounting for such nested effects.
Although moderate to severe OSA has been shown to con-
fer increased risk of ICH development in craniosynosto-
sis,10,39 it has not resulted in cortical thickness changes in
this study. The mechanism by which OSA is thought to con-
tribute to ICH is through hypercapnia leading to altered
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Figure 1: Cortical thickness color map overlaid on the pial surface of a 4-year-old patient with Crouzon syndrome. Occipital, axial, and frontal views
are shown respectively from left to right with a 0–5mm color-coded scale.
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cerebral hemodynamics.40 OSA diagnosis may not be
reflected in cortical changes because unlike papilloedema
and hydrocephalus, it does not appear to be a sequela of
longstanding ICH but rather an aetiology. Furthermore, the
duration of OSA is often limited as parents are regularly
coached regarding detection of symptoms and treatment
begins shortly after diagnosis. It seems prolonged exposure
to ICH is necessary to induce changes in cortical thickness
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Figure 2: Effects of categorical variables on cortical thickness progression. MRI, magnetic resonance imaging; OSA, obstructive sleep apnea; OFC,
occipitofrontal circumference.
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and transient OSA may be insufficient to produce such an
effect.
Occipitofrontal circumference measurement is a reliable
proxy for intracranial volume in syndromic craniosynosto-
sis and significant deflections in its progression have been
linked to ICH development, especially in the postoperative
period.9,41 However, we did not observe any changes in
cortical thickness as a result of OFC deflection in this
cohort. Skull growth restriction, as measured by OFC
deflection, is one factor among others that contribute to
ICH in a complex pathophysiology, which requires time to
develop. Although a significant amount of time is required
to develop both papilloedema and OFC curve deflection,
we attribute differences in significance observed in this
study to variability in what these parameters indicate.
Deflection of OFC curves indicate only skull growth
restriction, which is one of multiple contributors to ICH
in these patients. Conversely, papilloedema reflects a state
of ICH regardless of specific aetiology. Although many
patients with skull growth restriction go on to develop
papilloedema, it is not universally the case (32/56 patients
with OFC deflection were found to have papilloedema in
our cohort). This suggests that severity of ICH status, as
determined by papilloedema, rather than aetiology, is more
important with regard to cortical thinning.
Last, cerebellum tonsillar position did not correlate with
altered cortical thickness. The association of Chiari malfor-
mation type I with craniosynostosis is well established, but
the causes for descent of the tonsils may result from sus-
tained intracranial pressure elevation or may present as
syndrome-specific anomalies. Differing aetiologies of ton-
sillar position in our cohort could explain the lack of sig-
nificance with regard to cortical thickness.
There are several limitations to our study which should
be considered when interpreting our results. First, a signif-
icant portion of our data is cross-sectional, which makes
inferences concerning cortical development for patients
without repeated MRI difficult. Additionally, patients who
were excluded because of lack of successful thickness esti-
mate outputs could unpredictably affect outcomes (107/
147 patients were suitable for study), as a significant num-
ber may have pathology pertinent to cortical thickness
development. Although excluded cases may potentially
influence this analysis, an overwhelming majority (83%) of
cases were too young (<2y) to expect consistent grey-white
matter differentiation. Future efforts to evaluate potential
differences in white matter maturation rates may shed
more light on why these patients were unable to be
included. Last, cortical development is a complex process
which may be impacted by additional socio-economic or
other factors not addressed in this study.
This study demonstrates that patients with syndromic
craniosynostosis with a previous finding of papilloedema
have reduced cerebral cortex thickness. This association is
age-independent and is likely to be due to prolonged ICH
exposure. Clinically, this supports the need for preventative
rather than reactive treatment strategies. Although the effect
of surgical intervention is not directly evaluated here, our
craniofacial centre recommends early vault expansion during
this critical period of brain development. Future studies
should investigate potential changes in cortical thickness for
patients who undergo a first operation at an older age,
improved methods of ICH detection in younger patients,
and the effect of ICH on neuropsychological development.
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